Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV001799108 | SCV002042811 | benign | Breast and/or ovarian cancer | 2021-04-27 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002255683 | SCV002530220 | benign | Hereditary cancer-predisposing syndrome | 2021-05-30 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002255683 | SCV002667078 | benign | Hereditary cancer-predisposing syndrome | 2020-07-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomic Medicine, |
RCV002465891 | SCV002760521 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001579467 | SCV001807364 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001579467 | SCV001923530 | likely benign | not provided | no assertion criteria provided | clinical testing |